Loading clinical trials...
Loading clinical trials...
Open-label, Randomized, Parallel-group, Active-controlled, Multi-centre Non-inferiority Study of Dabigatran Etexilate Versus Standard of Care for Venous Thromboembolism Treatment in Children From Birth to Less Than 18 Years of Age
Conditions
Interventions
dabigatran etexilate
standard of care
Locations
65
United States
University of California Davis
Sacramento, California, United States
University of Miami
Miami, Florida, United States
St. Joseph's Children's Hospital
Tampa, Florida, United States
Blank Children's Hospital
Des Moines, Iowa, United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Boston Children's Hospital
Boston, Massachusetts, United States
Start Date
September 25, 2013
Primary Completion Date
October 16, 2019
Completion Date
November 14, 2019
Last Updated
July 7, 2020
NCT06189313
NCT07015905
NCT03728166
NCT06393868
NCT07140523
NCT07310693
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions